Rapid-Cycle Survey Collaborative for Provider and Public Input on Immunization Issues | RFA IP 25 111

Opportunity Information: Apply for RFA IP 25 111

The Centers for Disease Control and Prevention (CDC) is offering a discretionary cooperative agreement under the funding opportunity titled "Rapid-Cycle Survey Collaborative for Provider and Public Input on Immunization Issues" (Opportunity Number: RFA IP 25 111; CFDA: 93.185). The project is designed to generate quick, reliable, and nationally representative feedback on urgent and emerging immunization topics by surveying both healthcare providers and members of the public. The central idea is to create a rapid-cycle survey capability that can be used multiple times each year to capture shifting attitudes, practices, and barriers related to vaccination, then quickly share findings so they can be used in real-world public health decision-making.

The main objectives are twofold. First, the awardee is expected to conduct multiple surveys per year across the period of performance, using scientifically sound survey methods that achieve adequate response rates and produce results that can reasonably be generalized to the national population being studied. This implies careful attention to sampling frames, survey design, weighting and adjustment approaches, and strategies to reduce nonresponse bias so the data are credible for policy and program use. Second, the awardee must disseminate results broadly and in a timely way so the information can help shape vaccine recommendations, guide strategies to improve immunization coverage, and support contingency planning for urgent situations such as vaccine supply shortages or other fast-moving immunization challenges.

A defining feature of the opportunity is that it requires input from both clinicians and the public, rather than focusing on only one group. On the provider side, surveys must include at minimum pediatricians, family physicians, obstetrician/gynecologists, general internists, and pharmacists, reflecting the mix of professionals who routinely counsel patients, administer vaccines, and influence uptake across the lifespan. On the public side, the surveyed population must be adults age 18 and older, with attention to key subgroups that often sit at the center of immunization policy and communication decisions, including pregnant women, parents of children ages 0 to 5, and people living with chronic medical conditions. These groups are frequently prioritized because of their higher stakes in vaccination decisions, their greater interaction with healthcare systems, and their relevance to maternal, pediatric, and high-risk adult immunization strategies.

In practical terms, the CDC is looking for an organization that can stand up and maintain a repeatable, rapid survey operation: one that can field questions quickly when new issues arise, reach nationally representative samples of the required groups, and turn results around fast enough to be useful for decision-makers. Because this is a cooperative agreement, the CDC is likely to have substantial involvement in guiding priorities, coordinating on survey topics, and ensuring the outputs align with public health needs, rather than operating as a hands-off grant.

The opportunity is open to a broad range of eligible applicants, including state, county, and local governments; special district governments; independent school districts; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities/Indian housing authorities; and nonprofits with or without 501(c)(3) status, among others. The expected number of awards is one, with an award ceiling of $750,000. The posting lists an original closing date of 2025-02-06, and the opportunity was created on 2024-12-04. Overall, the grant is aimed at building a dependable, rapid feedback loop between the people who deliver vaccines, the people who receive them, and the public health systems that rely on timely data to respond to changing immunization conditions.

• The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Rapid-Cycle Survey Collaborative for Provider and Public Input on Immunization Issues" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.185.
• This funding opportunity was created on 2024-12-04.
• Applicants must submit their applications by 2025-02-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $750,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others.

Apply for RFA IP 25 111

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: